Archive ready

再生医療関連事業における細胞培養加工施設の稼働開始について

https://jholdings.co.jp/jhwp/wp-content/uploads/2025/12/20251216-001.pdf

May 14, 2026 at 05:20 AM JST•The archive page, viewer, and downloads use this saved version.

May 14, 2026 at 05:20 AM JST·jholdings.co.jp

The evidence pack includes HTML, screenshots, summaries, and metadata. It can be downloaded on Pro.

Saved PDF

再生医療関連事業における細胞培養加工施設の稼働開始について

Original URLhttps://jholdings.co.jp/jhwp/wp-content/uploads/2025/12/20251216-001.pdf

StartedMay 14, 2026 at 05:20 AM JST

File size0.47 MB

SHA-2566db1b20dd0e763212afa0c79811bdfeff596aa61c88e57721a511559f683891f

About this pageAI generated

This document is an announcement by J Holdings Inc. on December 16, 2025, regarding the commencement of operations at the cell culture processing facility 'Regentech Lab' established by its consolidated subsidiary, Advanced Regentech Co., Ltd. Located in Akasaka, Minato-ku, Tokyo, the RT Lab will manufacture and sell exosomes to medical institutions. Sales will begin this month, and after obtaining the manufacturing license for specific cell processing products, the lab plans to culture and process somatic stem cells. The impact on the company's performance for the fiscal year ending December 2025 is expected to be minimal.